For decades, experimental cancer drugs that did not provide measurable benefit to a significant number of patients in a clinical trial were considered “failed,” and further efforts to develop the drug for that use were shelved. The few patients who responded to such drugs were thought to have experienced a “miracle.”Read More
Exposure to dim light at night made breast tumors more resistant to tamoxifen in rats, but this resistance could be counteracted by melatonin supplements administered to the rats at nighttime.
In the coming months, we will share posts from advocates who participated in the AACR’s Scientist↔Survivor Program at the AACR Annual Meeting 2014 in San Diego, California. Today’s post is …Read More
Today’s early-career investigators are the future of cancer research and progress in the quest to prevent and cure cancer. The American Association for Cancer Research (AACR) recognizes the importance of …Read More
Philadelphia Inquirer senior health reporter Marie McCullough describes the challenge of pancreatic cancer and the efforts underway by the American Association for Cancer Research and its partners to combat the …Read More
Two papers in the journals of the American Association for Cancer Research this morning provide new information on tamoxifen, a widely used breast cancer treatment.Read More
The summer issue of Cancer Today is out and features stories on the challenge of having both cancer and diabetes, incorporating spirituality into cancer patients’ care, and how Ed Bradley …Read More
Last week, we launched a new logo and brand identity for the American Association for Cancer Research (AACR) and the AACR Foundation, and I am thrilled at the positive responses …Read More
When I was a child, the proximity of the Jersey Shore to my hometown made the beach a frequent destination. In the morning, my family would pile into the old …Read More
Welcome to Cancer Research Catalyst, the official blog of the American Association for Cancer Research (AACR).
With this blog, we aim to increase the spread of new knowledge about cancer while …